The present invention provides FGF-CX polypeptides and polynucleotides, and antibodies that immunospecifically bind to FGF-CX or any derivative, variant, mutant, or fragment of the FGF-CX polypeptide, polynucleotide or antibody. The invention additionally provides methods of use for the FGF-CX polypeptide, polynucleotide and antibody.

 
Web www.patentalert.com

< Triggered release from proteinoid microspheres

< Interleukin-19 antibodies

> Compounds that bind P2Y.sub.2 or P2Y.sub.1 receptors

> 4-dedimethylamino tetracycline compounds
~ 00266